T-cell receptor specific for H5 hemagglutinin-derived peptides (TCR-H5-HA)

T-cell receptors (TCRs) specific for H5 hemagglutinin (HA)-derived peptides are critical components of the adaptive immune system's response to highly pathogenic avian influenza (HPAI) H5N1. These receptors are expressed on the surface of T lymphocytes and are engineered or naturally selected to recognize specific amino acid sequences (epitopes) from the H5 HA protein when presented by Major Histocompatibility Complex (MHC) molecules. In the context of infection or vaccination, these TCRs mediate the identification and destruction of virus-infected cells, thereby limiting viral replication and spread. From a therapeutic perspective, these TCRs are being investigated for use in adoptive cell therapies, such as TCR-engineered T-cells (TCR-T), to provide immediate immunity against pandemic influenza strains. Understanding the structural basis of the TCR-peptide-MHC interaction is vital for designing universal vaccines and identifying conserved epitopes that can provide broad protection across different H5 clades.

Other names

H5N1-specific T-cell receptorHemagglutinin-specific TCRH5 HA-specific TCRAvian influenza-specific T-cell receptor

The T-cell receptor (TCR) recognizes specific H5 hemagglutinin (HA) peptides presented by Major Histocompatibility Complex (MHC) molecules on the surface of infected cells. This binding triggers a signaling cascade involving the CD3 complex, leading to T-cell proliferation, the release of cytotoxic granules (perforin and granzymes), and the secretion of pro-inflammatory cytokines like IFN-gamma to eliminate the virus-infected cells.